NASDAQ: CERT - Certara, Inc.

Yield per half year: +8.45%
Sector: Healthcare

Download the report: word Word , pdf PDF

1. Summary

Advantages

  • Positive review Current debt level 19.08% is below 100% and has decreased over 5 years from 38.88%.

Disadvantages

  • Negative review Price (15.92 $) is higher than fair price (14.22 $)
  • Negative review Dividends (0%) are below the sector average (1.871%).
  • Negative review The stock's return over the last year (-24.83%) is lower than the sector average (4432388531.56%).
  • Negative review The company's current efficiency (ROE=-5.21%) is lower than the sector average (ROE=11.82%)

2. Share price and performance

2.1. Share price

2.2. News

2.3. Market efficiency

Certara, Inc. Healthcare Index
7 days -1% 0% -4.9%
90 days -6% 4040409587.9% 2.7%
1 year -24.8% 4432388531.6% 24.5%

Negative review CERT vs Sector: Certara, Inc. has significantly underperformed the "Healthcare" sector by -4432388556.39% over the past year.

Negative review CERT vs Market: Certara, Inc. has significantly underperformed the market by -49.33% over the past year.

Positive review Stable price: CERT is not significantly more volatile than the rest of the market on "NASDAQ" over the last 3 months, with typical variations of +/- 5% per week.

Long period: CERT with weekly volatility of -0.4776% over the past year.

3. Summary of the report

3.1. General

P/E: 171.46
P/S: 8.16

3.2. Revenue

EPS -0.3483
ROE -5.21%
ROA -3.53%
ROIC -0.2%
Ebitda margin 19.79%

4. Fundamental Analysis

4.1. Stock price and price forecast

The fair price is calculated taking into account the Central Bank refinancing rate and earnings per share (EPS)

Negative review Above fair price: The current price (15.92 $) is higher than the fair price (14.22 $).

Negative review Price is higher than fair: The current price (15.92 $) is 10.7% higher than the fair price.

4.2. P/E

Negative review P/E vs Sector: The company's P/E (171.46) is higher than that of the sector as a whole (42.58).

Negative review P/E vs Market: The company's P/E (171.46) is higher than that of the market as a whole (54.92).

4.2.1 P/E Similar companies

4.3. P/BV

Positive review P/BV vs Sector: The company's P/BV (2.76) is lower than that of the sector as a whole (4.69).

Negative review P/BV vs Market: The company's P/BV (2.76) is higher than that of the market as a whole (2.35).

4.3.1 P/BV Similar companies

4.4. P/S

Negative review P/S vs Sector: The company's P/S indicator (8.16) is higher than that of the sector as a whole (4.77).

Positive review P/S vs Market: The company's P/S indicator (8.16) is lower than that of the market as a whole (9.99).

4.4.1 P/S Similar companies

4.5. EV/Ebitda

Negative review EV/Ebitda vs Sector: The company's EV/Ebitda (42.13) is higher than that of the sector as a whole (16.28).

Negative review EV/Ebitda vs Market: The company's EV/Ebitda (42.13) is higher than that of the market as a whole (22.79).

5. Profitability

5.1. Profitability and revenue

5.2. Earnings per share - EPS

5.3. Past profitability Ebitda

Positive review Yield Trend: Rising and has grown by 104.49% over the last 5 years.

Negative review Earnings Slowdown: The last year's return (0%) is below the 5-year average return (104.49%).

Negative review Profitability vs Sector: The return for the last year (0%) is lower than the return for the sector (1404.06%).

5.4. ROE

Negative review ROE vs Sector: The company's ROE (-5.21%) is lower than that of the sector as a whole (11.82%).

Negative review ROE vs Market: The company's ROE (-5.21%) is lower than that of the market as a whole (31.82%).

5.5. ROA

Negative review ROA vs Sector: The company's ROA (-3.53%) is lower than that of the sector as a whole (6.99%).

Negative review ROA vs Market: The company's ROA (-3.53%) is lower than that of the market as a whole (6.37%).

5.6. ROIC

Negative review ROIC vs Sector: The company's ROIC (-0.2%) is lower than that of the sector as a whole (13.31%).

Negative review ROIC vs Market: The company's ROIC (-0.2%) is lower than that of the market as a whole (10.68%).

6. Finance

6.1. Assets and debt

Positive review Debt level: (19.08%) is quite low in relation to assets.

Positive review Debt reduction: over 5 years, the debt has decreased from 38.88% to 19.08%.

Negative review Excess of debt: The debt is not covered by net income, percentage -538.27%.

6.2. Profit growth and share price

7. Dividends

7.1. Dividend yield vs Market

Negative review Low yield: The dividend yield of the company 0% is below the average for the sector '1.871%.

7.2. Stability and increase in payments

Negative review Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.

Negative review Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.

7.3. Payout percentage

Negative review Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.

8. Insider trades

8.1. Insider trading

Positive review Insider Buying Exceeds insider sales by 100% over the last 3 months.

8.2. Latest transactions

Transaction date Insider Type Price Volume Quantity
11.09.2023 Pedersen Leif E
PRESIDENT, CHIEF COMMERCAL OFF
Sale 14.6 747 870 51224
14.04.2023 Traynor Richard M.
SVP AND GENERAL COUNSEL
Sale 23.66 118 300 5000
27.12.2021 Traynor Richard M.
SVP AND GENERAL COUNSEL
Sale 29.3 87 900 3000
02.08.2021 EQT Avatar Parent L.P.
10% Owner
Sale 26 188 568 000 7252632